Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Committee OKs Retrospective Studies, But With Caveats

Executive Summary

FDA's Oncologic Drugs Advisory Committee agreed that retrospective studies can be used to support predictive biomarkers. The agency convened the meeting in hopes of coming away with guidance on how to assess forthcoming applications to restrict therapies to patients, using predictive biomarkers
Advertisement

Related Content

Enrichment Guidance To Prod Sponsors Toward Prospective Patient Stratification
FDA On Personalized Medicine: Don’t Skimp On Diagnostic Quality Development
FDA Drug Development Tool Guidance Leaves Door Open For Advisory Committee Reviews
FDA Drug Development Tool Guidance Leaves Door Open For Advisory Committee Reviews
FDA Aims For Flexibility In Upcoming Drug/Companion Diagnostic Guidance
FDA Aims For Flexibility In Upcoming Drug/Companion Diagnostic Guidance
Tissue Samples Will Play Important Role In Identifying Predictive Biomarkers
Tissue Samples Will Play Important Role In Identifying Predictive Biomarkers
Tissue Samples Will Play Important Role In Identifying Predictive Biomarkers
Advertisement
UsernamePublicRestriction

Register

PS050461

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel